US 11129844
Compositions and methods for modulating MECP2 expression
granted A61KA61K31/712A61P
Quick answer
US patent 11129844 (Compositions and methods for modulating MECP2 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 28 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K31/712, A61P, A61P25/22